Bambusa Therapeutics (BBTX) logo

Bambusa Therapeutics (BBTX) insider trading in the last 6 months

2 insiders bought $52.6M. No sales.

Filings: 5, in the last 6 months
Quality Score: 3, Below Average

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 5 tradesSee it live, free for 24 hours. No account. No card. Then keep going with a free account.

Form 4 filings, newest first

BuyRA Capital Management, L.P.$37.4M10% ownerat $16.00 on Nov 2, filed Nov 3
BuyRA Capital Management, L.P.$3.9M10% ownerat $14.92 on Oct 30, filed Nov 3
BuyRA Capital Management, L.P.$2.7M10% ownerat $14.23 on Oct 30, filed Nov 3

From SEC Form 4s, the newest filed Nov 3, 2026 · Insiders have 2 business days to file a trade

Pro members see every filing on BBTX with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Insider trades by person

Cluster buys at BBTX

2 insiders bought BBTX in the last 6 months: RA Capital Management, L.P. and Helmut Wolfgang Jeggle.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Questions about BBTX's insider trades

As of Nov 10, 2026: Bambusa Therapeutics (BBTX) has 5 insider filings on record in the last 6 months, the newest filed Nov 3, 2026. Its Quality Score is 3 (Below Average). Scores as of 11:01 AM ET, 15 minutes behind.

Are BBTX insiders buying or selling?

2 insiders bought $52.6M across 5 filings in the last 6 months. No open-⁠market sales on record. The newest filing: RA Capital Management, L.P., 10% owner, bought $37.4M on Nov 2, 2026. 2 insiders bought BBTX in the last 6 months: RA Capital Management, L.P. and Helmut Wolfgang Jeggle.

Who are BBTX's biggest insider sellers?

No BBTX insider sold shares on the open market in the last 6 months, as filed on Form 4.

When did a BBTX insider last buy?

RA Capital Management, L.P., 10% owner, bought BBTX shares ($37.4M) on Nov 2, 2026, filed Nov 3, 2026, the newest insider buy on record.

Bambusa Therapeutics's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech. BBTX is on insider buys, Nov 2 to 8, 2026.

Every insider trade, with its stock's score.

Real-time prices, every Form 4 on every stock with its Quality Score, sorting, filters, and optional alerts when the people you follow file.

See the last 30 days of insider trades

See it live, free for 24 hours. No account. No card. Then keep going with a free account.

Shares insiders bought or sold themselves, as filed on Form 4. Grants, option exercises, shares withheld for tax, and 10b5-1 plan sales are left out.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9, 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.